Product Information
FLUVOXAMINE MALEATE 50 MG TAB is a generic product labeled by Chartwell RX LLC, priced at $0.1954 per EA under NDC 62135093260. Its NADAC has been published 66 times since Jul 2, 2025.
FDA first approved this application on Feb 23, 2006.
Strength
50 mg/1
Manufacturer
Chartwell RX LLCNDC
62135093260
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
FLUVOXAMINE MALEATEApproval Type
Generic (ANDA)
FDA Application
ANDA075900FDA Approved
2/23/2006
On Market Since
2/23/2006
Pharmacological Classes
Price Statistics
The NADAC for FLUVOXAMINE MALEATE 50 MG TAB has been published 66 times since Jul 2, 2025, and over the history we have for it it has declined 14.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1954 per EA |
|---|---|
| All-time high | $0.2389 (Nov 12, 2025) |
| All-time low | $0.1954 (Sep 23, 2026) |
| 52-week high | $0.2389 |
| 52-week low | $0.1954 |
| Median price | $0.2190 |
| Average price | $0.2181 |
| Largest weekly change | -4.7% (Mar 18, 2026) |
| Weeks tracked | 66 |
| Tracking since | Jul 2, 2025 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Chartwell RX LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Fluvoxamine Maleate market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Serotonin Reuptake Inhibitor class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of FLUVOXAMINE MALEATE 50 MG TAB?
The current National Average Drug Acquisition Cost (NADAC) for FLUVOXAMINE MALEATE 50 MG TAB, manufactured by Chartwell RX LLC, is $0.1954 per EA (NDC 62135093260), effective Sep 30, 2026.
How has the price of FLUVOXAMINE MALEATE 50 MG TAB changed over time?
Over the history we have for it, the NADAC for FLUVOXAMINE MALEATE 50 MG TAB has declined 14.3%. It has been tracked across 66 weekly CMS publications since Jul 2, 2025.
What are the highest and lowest recorded NADAC prices for FLUVOXAMINE MALEATE 50 MG TAB?
Since Jul 2, 2025, the NADAC for FLUVOXAMINE MALEATE 50 MG TAB has ranged from a low of $0.1954 (Sep 23, 2026) to a high of $0.2389 (Nov 12, 2025), with a median of $0.2190 per EA.
Are there cheaper alternatives to FLUVOXAMINE MALEATE 50 MG TAB?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as FLUVOXAMINE MALEATE 50 MG TAB in a comparable dosage form, but none are currently priced below it.
Who manufactures FLUVOXAMINE MALEATE 50 MG TAB?
FLUVOXAMINE MALEATE 50 MG TAB (NDC 62135093260) is labeled by Chartwell RX LLC, and CMS classifies it as a generic product.